Study offers novel insight into cardiac arrhythmias, sudden cardiac death

User rating: 4.3 / 5 after 3 vote(s)

A new study by researchers at Rhode Island Hospital provides much-needed insight into the molecular mechanisms that cause arrythmia, or irregular heartbeat, and how it triggers sudden cardiac death, one of the nation’s leading killers. Their findings, published online in the Journal of Clinical Investigation, could pave the way for the development of new, genetically-targeted therapies to treat and prevent fatal arrythmias.


Full story »

All News summaries from Medicine & Health news
All News summaries for May 09, 2008

Prism glasses expand the view for patients with hemianopia

0 minute ago | User rating: not rated yet
Innovative prism glasses can significantly improve the vision and the daily lives of patients with hemianopia, a condition that blinds half the visual field in both eyes. The peripheral prism glasses, which were invented ...

Seeing Alzheimer's amyloids

1 minute ago | User rating: not rated yet
In an important step toward demystifying the role protein clumps play in the development of neurodegenerative disease, researchers have created a stunning three-dimensional picture of an Alzheimer’s peptide ...

New MRI technique developed at UT Southwestern detects subtle but serious brain injury

30 minutes ago | User rating: not rated yet
A new technique for analyzing magnetic resonance imaging data, developed by researchers at UT Southwestern Medical Center, can reveal serious brain injury missed by current tests and help predict a patient’s degree of recovery.

New approach to protect the hearts of patients with muscular dystrophy

31 minutes ago | User rating: not rated yet
A team of researchers has recently shown that the administration of sildenafil protects the heart in mice with Duchenne muscular dystrophy. This study was led by Dr. Christine Des Rosiers from the Université de Montréal and ...

Glypican-3 gene function in regulating body size helps inform novel cancer treatments

34 minutes ago | User rating: not rated yet
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have ...